We are live on ! Find out more
LUNG icon

Pulmonx

118 hedge funds and large institutions have $244M invested in Pulmonx in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 16

4% more funds holding

Funds holding: 114 → 118 (+4)

10% more capital inflows, than outflows

Capital inflows: $21.5M | Capital outflows: $19.6M

6% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.04% less ownership

Funds ownership: 90.88% → 90.84% (-0.04%)

100% less call options, than puts

Call options by funds: $4K | Put options by funds: $1.74M

Holders
118
Holders Change
+4
Holders Change %
+3.51%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
36
Reduced
34
Closed
16
Calls
$4​K
Puts
$1.74​M
Net Calls
-⁠$1.74​M
Net Calls Change
+$301​K

LUNG Hedge Fund Activity: Q4 2024 in Review

118 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q4 2024, worth a combined $244M — down 17% from $294M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new LUNG positions and 16 closed out — a net gain of 7 holders — while 36 added to existing stakes and 34 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $10.1M. The largest seller was Morgan Stanley, cutting an estimated $4.72M.

  • 118 institutional investors held Pulmonx (LUNG) as of Q4 2024, up from 114 in Q3 2024.
  • Funds reported $244M of Pulmonx stock for Q4 2024, down 17% quarter-over-quarter.
  • 23 funds opened new Pulmonx positions in Q4 2024 and 16 closed out, a net change of +7 holders.
  • The largest Pulmonx buyer in Q4 2024 was Deerfield Management, an estimated $10.1M added.
  • The largest Pulmonx seller in Q4 2024 was Morgan Stanley, an estimated $4.72M sold.

Based on aggregated 13F filings for Q4 2024.